Delivery Order SPE2DB20D1109-SPE2DB21FP94W
Award Date
9/3/21
Potential Completion Date
9/7/21
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,167.46, is a delivery order for 4565265690 - MESALAMINE DR 400 MG CAPSULE 180S. The contract has an ultimate completion date of July 29, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.71 firm fixed-price delivery order is for the supply of 4560971200 - MESALAMINE DR 400 MG CAPSULE 180S, with a period of performance through May 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,589.52 Firm Fixed Price Delivery Order covers the procurement of 4566901592 - MESALAMINE DR 400 MG CAPSULE 180S, with a period of performance through January 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,564.43, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product, with a completion date of May 3, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,382.57, is a delivery order for 4567178220 MESALAMINE DR 400 MG CAPSULE 180S. It is a firm fixed price contract with a completion date of February 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.02, is a delivery order for 4567340127 - MESALAMINE DR 400 MG CAPSULE 180S. The contract has an ultimate completion date of February 24, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FAVF2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,229.45 Firm Fixed Price Delivery Order is for the supply of MESALAMINE DR 400 MG CAPSULE 180S, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUM77, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,567,223,297 units of MESALAMINE DR 400 MG CAPSULE 180S, with a ceiling value of $5,218.80. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The period of performance runs through February 11, 2025. This contract award was not designated with any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,594.32 Firm Fixed Price delivery order is for the supply of 4566550847 MESALAMINE DR 1.2 GM TABLET 120S. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,981.13 firm fixed-price delivery order covers the provision of 4567174640 - MESALAMINE DR 400 MG CAPSULE 180S, with a completion date of February 6, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...